HCS Pharma is one of the winner of the Lab’StartUp village, organized by Forum Labo! As such, we have won a stand in the heart of the forum (March 26-28, 2019)… Thanks a lot to Read more…
Extracellular matrix (ECM) is known to have an influence on physiological processes and on tumour progression: ECM properties (composition, stiffness) modulate cell proliferation, migration, invasion and epithelial-to-mesenchymal transition (EMT). For example, EMT is inhibited by Read more…
Large number of visitors came to Cosmet’agora last week to discover the last innovations in cosmetic formulation. It was a great opportunity to discuss with leader companies developing active ingredients and to feel emerging trends Read more…
Our study directors Elodie and Pierre-Jean enjoyed the last edition of Health Ingredients Europe, which took place in Frankfurt (Germany) from the 27th to the 28th of November 2018. For their first time in HIE, Read more…
HCS Pharma team enjoyed attending BioFit 2018 and hosted events in Lille last week! Our business developer Nathalie had many fruitful BtoB meetings along the convention, and our study director Elodie could meet lots of Read more…
Our study directors Elodie and Pierre-Jean will attend “HI Europe” in Frankfurt next week. We cordially invite you to discuss with them, they will be happy to present our imaging services related to nutraceutical testing! We Read more…
In this article, researchers from Sorbonne University (Paris, France) proposed an explanation for the patterns followed by breast cancer cells when seeded in BIOMIMESYS, i.e. spherical aggregates. Usually, mathematical models dealing with the formation of Read more…
Last week we attended ELRIG UK Drug Discovery meeting in ExCeL London, and it was a great pleasure for us to present our poster about neurotoxicity testing using HCS there. Many interesting posters were displayed Read more…
Our study director Elodie will attend Drug Discovery 2018 – THE ELRIG‘s flagship conference – which will take place in London next week! We are looking forward to presenting our poster about neurotoxicity testing. Don’t hesitate to visit Read more…
It is a great pleasure for us to welcome a new member in our scientific advisory board, Dr Samuel Meignan! He will for sure help us to develop relevant models related to oncology therapeutic area. Read more…
Last week we had the pleasure to attend the first SLAS Europe (Society for Laboratory Automation and Screening) meeting, which took place in the great Brussels Square meeting centre (Belgium) between the 27th and the Read more…
HCS pharma has organized its second scientific advisory board! We were pleased to gather around the table (physically or via a Webex visioconference for those who could not make the trip) David Devos, Roméo Cecchelli, Read more…
Since the liver is responsible for the selective uptake, metabolism and excretion of xenobiotics, this organ is highly predisposed to drug-induced toxicity: this essential function is the primary reason for the failure of pharmaceuticals during Read more…
We had the pleasure to attend ELRIG Fr meeting in Bischoffsheim (near Strasbourg) on the 23-24th of May. There we enjoyed meeting our partners Molecular Devices and Integra biosciences, and seeing great presentations about the Read more…
The first EUROoC meeting, dealing with organ-on-chip research and organized by the Chemical and Biological Microsystems Society (CBMS), will take place on the 24th-25th of May 2018 in Stuttgart (Germany). Interestingly, this new workshop will address the engineering challenges Read more…
Next week (the 23th and the 24th of May), we will be in Strasbourg to participate to ELRIGfr event, where we will present two posters. The first poster is about BIOMIMESYS® hydroscaffold for 3D cell culture and Read more…
Thanks a lot to Integra biosciences‘ and Molecular Devices‘ teams to have welcomed us on their respective booths at Forum Labo Lyon! It was a great pleasure to take part in this event by their Read more…
The annual congress of the SCMC (French Brain and Cerebrovascular Diseases Society) took place in Paris last week. The meeting began with a mini-symposium entitled “Nanoparticles and the brain”, during which the therapeutic potential of Read more…
It was a great pleasure to participate for the first time in Brains4brain congress, which took place in Frankfurt last week! The interventions from basic researchers, medical doctors and private companies all aimed at deepening Read more…
Following the Rare Disease Day, we would like to highlight the next international workshop of BRAINS FOR BRAIN (B4B) Foundation, which will take place in Frankfurt (Germany) between the 8th and the 10th of March. Read more…
Adipose tissue is vitally important to various normal processes of the human body, and it has also many implications for human disease states. Obesity is a common health problem and is considered as a major Read more…
Le colloque annuel de la Société Cerveau et Maladies Cérébrovasculaires (SCMC) est annoncé dans les locaux de la CAHPP à Paris le 15 mars prochain, avec au programme un mini-symposium « Nanoparticules et cerveau » avec les Read more…
In a study published last October in the journal Stem Cell Research, Chandrasekaran et al. compared the induction of neural progenitor cells (NPCs) from human induced pluripotent stem cells (hiPSCs) obtained by 2D and 3D Read more…